Processa Pharmaceuticals Inc (PCSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,100 | -14,414 | -4,679 | -1,608 | -874 |
| Depreciation Amortization | 199 | 804 | 760 | 402 | 201 |
| Income taxes - deferred | -89 | -1,001 | -286 | -216 | -128 |
| Accounts payable and accrued liabilities | -144 | 245 | 352 | -2 | 18 |
| Other Working Capital | -583 | -140 | 736 | 226 | 136 |
| Other Operating Activity | 473 | 11,363 | 2,249 | 301 | 102 |
| Operating Cash Flow | $-2,244 | $-3,143 | $-868 | $-897 | $-547 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 863 | 863 | 500 | N/A |
| Common Stock Issued | 9,876 | 17,101 | N/A | N/A | N/A |
| Other Financing Activity | 0 | -95 | -361 | 158 | -3 |
| Financing Cash Flow | $9,876 | $17,868 | $502 | $658 | $-3 |
| Beginning Cash Position | 15,416 | 692 | 692 | 692 | 692 |
| End Cash Position | 23,048 | 15,416 | 325 | 453 | 142 |
| Net Cash Flow | $7,632 | $14,725 | $-366 | $-239 | $-549 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,244 | -3,143 | -868 | -897 | -547 |
| Free Cash Flow | -2,244 | -3,143 | -868 | -897 | -547 |